Abbott Laboratories Articles
Abbott to expand in Japan
24 March 2003
Abbott starts Humira trials in psoriasis
17 March 2003
AIDS group warns over Roche
17 March 2003
Obesity: "unmet needs create huge potential"
17 March 2003
Gensia Sicor gets US ok for generic Levophed
10 March 2003
US pharmacy chains offer generics under Together Rx discount plan
24 February 2003
New data support efficacy of GW433908
24 February 2003
Boeh Ingelheim's tipranavir for PI resistance
24 February 2003
Abbott resumes shares repurchase program
24 February 2003
Abbott Labs UK receives special award for innovation
24 February 2003
Boeh Ingelheim starts two mega-trials
24 February 2003
Update: Abbott says atrasentan trial misses endpoint
17 February 2003
Stock Commentary - Week to Feb 10 - New York
17 February 2003
GSK, Vertex unveil new data on HIV prodrug
17 February 2003
Abbott says atrasentan trial misses endpoint
17 February 2003
Axcan outperforms in 1st qtr on acquisitions
17 February 2003
Monoclonal antibodies on the cusp of strong growth?
10 February 2003
Myriad uncovers new depression gene
10 February 2003
New report sees big changes for global antibiotics market
10 February 2003
Tokyo pharma stocks - week to Jan 20
27 January 2003
SangStat files ciclosporin capsules in Europe
27 January 2003
Update - Amgen says Enbrel psoriasis trial is positive
27 January 2003
Abbott's profits up 2%, forecasts lowered
27 January 2003
Abbott and Compugen forge alliance
20 January 2003
APP to sell Calcijex generic in USA
20 January 2003
Robust Takeda faces growing competition
13 January 2003
Stock Commentary - New York
13 January 2003
Medtronic to test drug-eluting stent
13 January 2003
Round-up of pharmaceutical mergers and acquisitions during 2001
13 January 2003
Wyeth, Abbott accused over "false" prices
13 January 2003
Antisoma/Roche cancer deal complete
13 January 2003
Humira launch hits Abbott forecast
6 January 2003
New York Stock Commentary - 2 weeks to Dec 30
6 January 2003
Abbott to get $1B syndicated loan
6 January 2003
Abbott gets approval for blockbuster candidate Humira in USA
6 January 2003
Abbott invests $50M in new Kansas facility
6 January 2003
Abbott gains FDA OK for once-daily Depakote
6 January 2003
Bayer to co-market BI's telmisartan
19 August 2002
Abbott Labs warned over AD reporting
12 August 2002
Stock Commentary - New York
5 August 2002
Triangle's Coviracil trial "un-blinded"
5 August 2002
US big pharma Rx card "beating other plans"
5 August 2002
Abbott's Synthroid FDA approved
5 August 2002
Tokyo pharma stocks - week to July 15
22 July 2002
Karo Bio 2nd-qtr losses down by 7%
22 July 2002
Caribbean AIDS Rx deal: other states may join
22 July 2002
Abbott to get Synthroid approval by August?
22 July 2002
No resistance at three years with Kaletra
15 July 2002
MaxCmin 1 trial in favor of saquinavir
15 July 2002
France forms Strategic Council for Innovation
15 July 2002
Caribbean/pharma HIV cut-price drug deal
15 July 2002
CPMP backs safety of Abbott's sibutramine
8 July 2002
Abbott and Celera in disease products JV
1 July 2002
Abbott cuts HIV/AIDS drug prices further
24 June 2002
CPMP backs new schedule for Roche HIV drug
24 June 2002
Stock Commentary - New York
24 June 2002
TAP Pharma among first to adopt PhRMA code
24 June 2002
Future competition in AECB market
17 June 2002
Britannia plans nasal drug for impotence
10 June 2002
US joint industry Rx card plan starts up
10 June 2002
Abbott faces charges over "withheld data"
3 June 2002
Stock Commentary - New York
27 May 2002
Abbott, S-P under FDA investigation
20 May 2002
CAT reports progress with ophthalmic drug
13 May 2002
Abbott, NaPro get OK for generic Taxol in USA
13 May 2002
Sigma buys bundle of Wyeth brands
13 May 2002
Tokyo pharma stocks - week to April 29
6 May 2002
New book addresses lack of drug coverage
6 May 2002
Tokyo pharma stocks - week to April 22
29 April 2002
UK Queen's Awards increase in pharma industry
29 April 2002
Abbott taking full control of Hokuriku
29 April 2002
World drug sales up 12% in year to Feb
22 April 2002
Pharma alliance to offer savings in USA
22 April 2002
TAP gets fast-track review of Prevacid for children
22 April 2002
Pharmacia ups Abbott India offer
15 April 2002
Biocompatibles to complete sale
15 April 2002
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
